Loading
Food and Beverage
6 min read
Areas of Expertise :
Advertising, Marketing, Nutrition, Pediatrics, Economic Damages
Published Date:
Last Modified Date:
Jurisdiction:
Federal. Second Circuit
The Gerber Good Start Gentle infant formula litigation was a U.S. consumer protection class action examining whether certain marketing and advertising statements were misleading to reasonable consumers. The dispute centered on representations suggesting that the product offered special or clinically supported benefits related to allergy risk, particularly when compared to standard infant formulas.
Rather than alleging personal injury, product defects, or regulatory violations, plaintiffs framed their claims around deceptive marketing practices and economic harm. They alleged that Gerber’s advertising conveyed messages that exceeded the level of scientific support available at the time, leading consumers to pay a price premium for the product. The claims were asserted under state consumer protection statutes, including New York and Florida laws governing deceptive and unfair trade practices.
The litigation ultimately concluded through a court-approved class settlement. It is frequently cited in discussions of how courts evaluate implied health-benefit claims, scientific substantiation disputes, and the role of expert testimony in consumer class actions involving regulated products.
Between 2015 and 2017, multiple consumer class actions were filed in the U.S. District Court for the Eastern District of New York by purchasers of Gerber Good Start Gentle infant formula. These actions were brought by consumers in different jurisdictions, including New York and Florida, and were later consolidated for coordinated discovery and pretrial proceedings. Plaintiffs alleged that Gerber’s marketing conveyed misleading messages implying that the formula reduced the risk of allergies or provided uniquely supported health benefits. Importantly, the claims sought recovery for alleged economic injury, namely, the premium paid for the product, rather than compensation for medical or personal harm.
Following discovery and motion practice, the court granted class certification for New York and Florida purchasers who bought Gerber Good Start Gentle during the defined class period, which ran from October 10, 2011 through April 23, 2016. In certifying the classes, the court found that common questions, particularly whether the challenged advertising was deceptive and whether consumers paid a price premium as a result, were capable of resolution on a classwide basis. This ruling allowed the case to proceed as a consumer class action limited to economic damages theories and significantly increased the litigation’s stakes by aggregating individual consumer claims.
A pivotal phase of the litigation occurred when the court addressed summary judgment motions and disputes over expert testimony. The court evaluated competing expert opinions concerning infant nutrition science, the scientific support for allergy-related marketing claims, and proposed damages methodologies. The court declined to exclude the defendant’s medical expert in full but imposed meaningful limitations on the scope of testimony. In particular, the court emphasized that expert opinions addressing scientific support had to be grounded in the body of research available at the time the challenged marketing statements were first disseminated.
The court also addressed plaintiffs’ damages theories, concluding that consumer protection claims under the applicable state laws did not require extrinsic consumer survey evidence to survive summary judgment. That determination clarified the evidentiary threshold for proving deception and economic harm at this stage of the case.
After extended litigation, expert discovery, and motion practice, the parties reached a negotiated class settlement. On May 2, 2025, the court granted preliminary approval of the proposed settlement, finding that it warranted notice to the class and further evaluation under Rule 23 standards. Preliminary approval reflected the court’s view that the settlement fell within the range of potential approval outcomes, while reserving final judgment pending class notice and consideration of objections.
Following notice to class members, review of submissions, and consideration of objections, the court granted final approval of the settlement on September 29, 2025. The court entered judgment dismissing the consolidated actions with prejudice, concluding that the settlement was fair, reasonable, and adequate in light of the litigation risks, expert disputes, and costs associated with continued proceedings. The approval brought the multi-year litigation to a close without a judicial determination on the merits of the challenged advertising claims.
Court:
United States District Court for the Eastern District of New York
Case Name:
Hasemann v. Gerber Products Co.
Advertising and Marketing
Allergy Immunology
Baby Formula
Consumer Fraud
Consumer Protection
Deceptive Advertising
Diet and Nutrition
Economic Analysis
The Gerber Good Start Gentle infant formula litigation was a U.S. consumer protection class action examining whether certain marketing and advertising statements were misleading to reasonable consumers. The dispute centered on representations suggesting that the product offered special or clinically supported benefits related to allergy risk, particularly when compared to standard infant formulas.
Rather than alleging personal injury, product defects, or regulatory violations, plaintiffs framed their claims around deceptive marketing practices and economic harm. They alleged that Gerber’s advertising conveyed messages that exceeded the level of scientific support available at the time, leading consumers to pay a price premium for the product. The claims were asserted under state consumer protection statutes, including New York and Florida laws governing deceptive and unfair trade practices.
The litigation ultimately concluded through a court-approved class settlement. It is frequently cited in discussions of how courts evaluate implied health-benefit claims, scientific substantiation disputes, and the role of expert testimony in consumer class actions involving regulated products.
Between 2015 and 2017, multiple consumer class actions were filed in the U.S. District Court for the Eastern District of New York by purchasers of Gerber Good Start Gentle infant formula. These actions were brought by consumers in different jurisdictions, including New York and Florida, and were later consolidated for coordinated discovery and pretrial proceedings. Plaintiffs alleged that Gerber’s marketing conveyed misleading messages implying that the formula reduced the risk of allergies or provided uniquely supported health benefits. Importantly, the claims sought recovery for alleged economic injury, namely, the premium paid for the product, rather than compensation for medical or personal harm.
Following discovery and motion practice, the court granted class certification for New York and Florida purchasers who bought Gerber Good Start Gentle during the defined class period, which ran from October 10, 2011 through April 23, 2016. In certifying the classes, the court found that common questions, particularly whether the challenged advertising was deceptive and whether consumers paid a price premium as a result, were capable of resolution on a classwide basis. This ruling allowed the case to proceed as a consumer class action limited to economic damages theories and significantly increased the litigation’s stakes by aggregating individual consumer claims.
A pivotal phase of the litigation occurred when the court addressed summary judgment motions and disputes over expert testimony. The court evaluated competing expert opinions concerning infant nutrition science, the scientific support for allergy-related marketing claims, and proposed damages methodologies. The court declined to exclude the defendant’s medical expert in full but imposed meaningful limitations on the scope of testimony. In particular, the court emphasized that expert opinions addressing scientific support had to be grounded in the body of research available at the time the challenged marketing statements were first disseminated.
The court also addressed plaintiffs’ damages theories, concluding that consumer protection claims under the applicable state laws did not require extrinsic consumer survey evidence to survive summary judgment. That determination clarified the evidentiary threshold for proving deception and economic harm at this stage of the case.
After extended litigation, expert discovery, and motion practice, the parties reached a negotiated class settlement. On May 2, 2025, the court granted preliminary approval of the proposed settlement, finding that it warranted notice to the class and further evaluation under Rule 23 standards. Preliminary approval reflected the court’s view that the settlement fell within the range of potential approval outcomes, while reserving final judgment pending class notice and consideration of objections.
Following notice to class members, review of submissions, and consideration of objections, the court granted final approval of the settlement on September 29, 2025. The court entered judgment dismissing the consolidated actions with prejudice, concluding that the settlement was fair, reasonable, and adequate in light of the litigation risks, expert disputes, and costs associated with continued proceedings. The approval brought the multi-year litigation to a close without a judicial determination on the merits of the challenged advertising claims.
Medical and Pediatric Expert Witness (Defense)
José M. Saavedra, M.D., retained by the defendant, was designated to address issues related to infant nutrition, allergy development, and whether the challenged marketing statements were consistent with the medical literature available during the relevant time period. Plaintiffs sought to limit aspects of his testimony, and the court permitted his opinions subject to specific temporal and methodological constraints.
The ruling highlights the careful scrutiny courts apply to expert testimony in cases involving health-related advertising, particularly where scientific understanding evolves over time.
Economic Damages Expert Witness (Plaintiff)
Plaintiffs relied on damages experts including Dr. Stefan Boedeker and Gregory Pinsonneault of LitiNomics to support a price-premium theory of economic injury. These experts analyzed whether consumers allegedly paid more for the product as a result of the challenged marketing claims.
The court evaluated these opinions in assessing classwide proof and the viability of plaintiffs’ damages methodologies, reinforcing the need for damages models to be closely tethered to the alleged misrepresentations.
Consumer Protection Expert Witness
In cases involving alleged deceptive marketing, parties may also rely on a consumer protection or advertising practices expert to address how marketing claims are commonly evaluated under state unfair and deceptive trade practice laws. Such experts typically assess the overall impression created by advertising, including implied messages, disclosures, and context, rather than focusing solely on isolated statements.
Health-Related Marketing Claims Receive Heightened Scrutiny
Courts closely examine advertising claims tied to health or pediatric use, especially where marketing implies reduced risk or clinically supported benefits.
Implied Messages May Be Actionable
Liability may arise from the overall impression conveyed by advertising, not solely from explicit statements. Courts consider how reasonable consumers could interpret implied messages.
Expert Testimony Is Influential but Narrowly Confined
Expert opinions often shape outcomes in health-related marketing cases, but courts impose strict limits tied to methodology, relevance, and the state of scientific knowledge during the marketing period.
Economic Damages Models Must Match the Theory of Deception
Price-premium theories remain common, but courts scrutinize whether damages models reliably connect the challenged advertising to alleged economic harm on a classwide basis.
Regulatory Compliance Does Not Resolve Consumer Protection Liability
Regulatory context informs analysis but does not, by itself, determine liability under state consumer protection laws.
Expert Uncertainty Often Drives Settlement Decisions
Disputes over expert admissibility and damages proof frequently influence settlement timing and structure in complex consumer class actions.
The resolution of the Gerber Good Start Gentle class action demonstrates how courts analyze deceptive marketing claims involving health and nutrition products. The case highlights the importance of substantiated advertising, disciplined expert analysis, and careful evaluation of economic injury theories. For practitioners, it also illustrates how expert admissibility rulings can materially affect litigation strategy and settlement dynamics in consumer protection cases involving regulated products.
Was this case about personal injury to infants?
No. The claims focused on alleged economic harm arising from deceptive marketing, not physical injury or medical damages.
Did the court rule that Gerber’s product was unsafe?
No. The litigation addressed marketing representations and consumer protection issues, not product safety or regulatory compliance determinations.
Why were experts important in this case?
Experts played a central role in evaluating scientific substantiation, assessing alleged price-premium damages, and informing the court’s rulings on admissibility and classwide proof.
Is this case relevant beyond infant formula products?
Yes. The case is often referenced in broader discussions of health-benefit advertising, substantiation standards, and expert testimony in consumer protection class actions.
What did the settlement resolve?
The settlement resolved the consumer protection claims and resulted in dismissal of the consolidated actions with prejudice, without a judicial finding on the merits of the challenged advertising claims.
Medical and Pediatric Expert Witness (Defense)
José M. Saavedra, M.D., retained by the defendant, was designated to address issues related to infant nutrition, allergy development, and whether the challenged marketing statements were consistent with the medical literature available during the relevant time period. Plaintiffs sought to limit aspects of his testimony, and the court permitted his opinions subject to specific temporal and methodological constraints.
The ruling highlights the careful scrutiny courts apply to expert testimony in cases involving health-related advertising, particularly where scientific understanding evolves over time.
Economic Damages Expert Witness (Plaintiff)
Plaintiffs relied on damages experts including Dr. Stefan Boedeker and Gregory Pinsonneault of LitiNomics to support a price-premium theory of economic injury. These experts analyzed whether consumers allegedly paid more for the product as a result of the challenged marketing claims.
The court evaluated these opinions in assessing classwide proof and the viability of plaintiffs’ damages methodologies, reinforcing the need for damages models to be closely tethered to the alleged misrepresentations.
Consumer Protection Expert Witness
In cases involving alleged deceptive marketing, parties may also rely on a consumer protection or advertising practices expert to address how marketing claims are commonly evaluated under state unfair and deceptive trade practice laws. Such experts typically assess the overall impression created by advertising, including implied messages, disclosures, and context, rather than focusing solely on isolated statements.
Health-Related Marketing Claims Receive Heightened Scrutiny
Courts closely examine advertising claims tied to health or pediatric use, especially where marketing implies reduced risk or clinically supported benefits.
Implied Messages May Be Actionable
Liability may arise from the overall impression conveyed by advertising, not solely from explicit statements. Courts consider how reasonable consumers could interpret implied messages.
Expert Testimony Is Influential but Narrowly Confined
Expert opinions often shape outcomes in health-related marketing cases, but courts impose strict limits tied to methodology, relevance, and the state of scientific knowledge during the marketing period.
Economic Damages Models Must Match the Theory of Deception
Price-premium theories remain common, but courts scrutinize whether damages models reliably connect the challenged advertising to alleged economic harm on a classwide basis.
Regulatory Compliance Does Not Resolve Consumer Protection Liability
Regulatory context informs analysis but does not, by itself, determine liability under state consumer protection laws.
Expert Uncertainty Often Drives Settlement Decisions
Disputes over expert admissibility and damages proof frequently influence settlement timing and structure in complex consumer class actions.
The resolution of the Gerber Good Start Gentle class action demonstrates how courts analyze deceptive marketing claims involving health and nutrition products. The case highlights the importance of substantiated advertising, disciplined expert analysis, and careful evaluation of economic injury theories. For practitioners, it also illustrates how expert admissibility rulings can materially affect litigation strategy and settlement dynamics in consumer protection cases involving regulated products.
Was this case about personal injury to infants?
No. The claims focused on alleged economic harm arising from deceptive marketing, not physical injury or medical damages.
Did the court rule that Gerber’s product was unsafe?
No. The litigation addressed marketing representations and consumer protection issues, not product safety or regulatory compliance determinations.
Why were experts important in this case?
Experts played a central role in evaluating scientific substantiation, assessing alleged price-premium damages, and informing the court’s rulings on admissibility and classwide proof.
Is this case relevant beyond infant formula products?
Yes. The case is often referenced in broader discussions of health-benefit advertising, substantiation standards, and expert testimony in consumer protection class actions.
What did the settlement resolve?
The settlement resolved the consumer protection claims and resulted in dismissal of the consolidated actions with prejudice, without a judicial finding on the merits of the challenged advertising claims.
Advertising and Marketing
Allergy Immunology
Baby Formula
Consumer Fraud
Consumer Protection
Deceptive Advertising
Diet and Nutrition
Economic Analysis
Wage And Hour Disputes, +4
Food and Beverage
Food And Beverage, +4
Food and Beverage